Gut Microbiome Alterations in Colorectal Cancer: Mechanisms, Therapeutic Strategies, and Precision Oncology Perspectives
Cancers · 10.07.2025 · 17 (14) · 2294
DOI: 10.3390/cancers17142294 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 10.07.2025. Verfasst von Miriam Tudorache und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Carol Davila University of Medicine and Pharmacy Bucharest, 050474 Bucharest, Romania. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Romanian Ministry of Research, Innovation, and Digitalization’s grant, European Union.
Abstract (Originalsprache)
Colorectal cancer (CRC) is one of the most prevalent and lethal oncological diseases worldwide, with a concerning rise in incidence, particularly in developing countries. Recent advances in genetic sequencing have revealed that the gut microbiome plays a crucial role in CRC development. Mechanisms such as chronic inflammation, metabolic alterations, and oncogenic pathways have demonstrated that dysbiosis, a disruption of the gut microbiome, is linked to CRC. Associations have been found between tumor progression, treatment resistance, and pathogenic microbes such as Fusobacterium nucleatum and Escherichia coli. A promising approach for CRC prevention and treatment is microbiome manipulation through interventions such as probiotics, prebiotics, fecal microbiota transplantation, and selective antibiotics. This article explores how gut microbiome alterations influence CRC pathogenesis and examines microbiome modulation strategies currently used as adjuncts to traditional treatments. Advances in artificial intelligence, single-cell and spatial transcriptomics, and large-scale initiatives such as the ONCOBIOME Project are paving the way for the identification of microbiome-derived biomarkers for early CRC detection and personalized treatment. Despite promising progress, challenges such as interindividual variability, causal inference, and regulatory hurdles must be addressed. Future integration of microbiome analysis into multi-omics frameworks holds great potential to revolutionize precision oncology in CRC management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Carol Davila University of Medicine and Pharmacy Bucharest, 050474 Bucharest, Romania.
- Innovation and eHealth Center, Carol Davila University of Medicine and Pharmacy Bucharest, 010451 Bucharest, Romania.
- Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania.
- Research Institute of University of Bucharest (ICUB), University of Bucharest, 050663 Bucharest, Romania.
- eBio-Hub Centre of Excellence in Bioengineering, National University of Science and Technology Politehnica Bucharest, 060042 Bucharest, Romania.
- General Surgery Department, Carol Davila University of Medicine and Pharmacy Bucharest, 050474 Bucharest, Romania.
ORCID-Profile: Andreea-Ramona Treteanu, Gratiela Gradisteanu Pircalabioru, Octavian Andronic
Förderung
- Romanian Ministry of Research, Innovation, and Digitalization’s grant
- European Union
Zitieren
APA
Tudorache, M., Treteanu, A. R., Gradisteanu Pircalabioru, G., Lixandru-Petre, I. O., Bolocan, A., & Andronic, O. (2025). Gut Microbiome Alterations in Colorectal Cancer: Mechanisms, Therapeutic Strategies, and Precision Oncology Perspectives. Cancers, 17(14), 2294. https://doi.org/10.3390/cancers17142294
Vancouver
Tudorache M, Treteanu AR, Gradisteanu Pircalabioru G, Lixandru-Petre IO, Bolocan A, Andronic O. Gut Microbiome Alterations in Colorectal Cancer: Mechanisms, Therapeutic Strategies, and Precision Oncology Perspectives. Cancers. 2025;17(14):2294. doi:10.3390/cancers17142294
BibTeX
@article{Tudorache2025,
author = {Tudorache, Miriam and Treteanu, Andreea-Ramona and Gradisteanu Pircalabioru, Gratiela and Lixandru-Petre, Irina-Oana and Bolocan, Alexandra and Andronic, Octavian},
title = {Gut Microbiome Alterations in Colorectal Cancer: Mechanisms, Therapeutic Strategies, and Precision Oncology Perspectives},
journal = {Cancers},
year = {2025},
volume = {17},
number = {14},
pages = {2294},
doi = {10.3390/cancers17142294}
}
EUVIMED